These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 1654597

  • 1. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
    Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher FJ.
    Science; 1991 Sep 27; 253(5027):1550-3. PubMed ID: 1654597
    [Abstract] [Full Text] [Related]

  • 2. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
    Gashler AL, Bonthron DT, Madden SL, Rauscher FJ, Collins T, Sukhatme VP.
    Proc Natl Acad Sci U S A; 1992 Nov 15; 89(22):10984-8. PubMed ID: 1332065
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus.
    Morris JF, Madden SL, Tournay OE, Cook DM, Sukhatme VP, Rauscher FJ.
    Oncogene; 1991 Dec 15; 6(12):2339-48. PubMed ID: 1662794
    [Abstract] [Full Text] [Related]

  • 4. A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein.
    Madden SL, Cook DM, Rauscher FJ.
    Oncogene; 1993 Jul 15; 8(7):1713-20. PubMed ID: 8510918
    [Abstract] [Full Text] [Related]

  • 5. Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene.
    Telerman A, Dodemont H, Degraef C, Galand P, Bauwens S, Van Oostveldt P, Amson RB.
    Oncogene; 1992 Dec 15; 7(12):2545-8. PubMed ID: 1334252
    [Abstract] [Full Text] [Related]

  • 6. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S, Tomlinson G, Nisen P, Haber DA.
    Cancer Res; 1993 Oct 15; 53(20):4757-60. PubMed ID: 8402654
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
    Lee YI, Kim SJ.
    DNA Cell Biol; 1996 Feb 15; 15(2):99-104. PubMed ID: 8634146
    [Abstract] [Full Text] [Related]

  • 8. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F, Barilla KC, Hamilton TB, Iskandar M, Romaniuk PJ.
    Biochemistry; 1996 Sep 17; 35(37):12070-6. PubMed ID: 8810912
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V, Menke AL, Attema J, Haneveld JK, Riteco N, van Steenbrugge GJ, van der Eb AJ, Jochemsen AG.
    Oncogene; 2000 Feb 10; 19(6):791-800. PubMed ID: 10698497
    [Abstract] [Full Text] [Related]

  • 12. Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1.
    Goodyer P, Dehbi M, Torban E, Bruening W, Pelletier J.
    Oncogene; 1995 Mar 16; 10(6):1125-9. PubMed ID: 7700638
    [Abstract] [Full Text] [Related]

  • 13. Sequence of the WT1 upstream region including the Wit-1 gene.
    Gessler M, Bruns GA.
    Genomics; 1993 Aug 16; 17(2):499-501. PubMed ID: 8406502
    [Abstract] [Full Text] [Related]

  • 14. RNA binding by the Wilms tumor suppressor zinc finger proteins.
    Caricasole A, Duarte A, Larsson SH, Hastie ND, Little M, Holmes G, Todorov I, Ward A.
    Proc Natl Acad Sci U S A; 1996 Jul 23; 93(15):7562-6. PubMed ID: 8755514
    [Abstract] [Full Text] [Related]

  • 15. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor.
    Rauscher FJ.
    FASEB J; 1993 Jul 23; 7(10):896-903. PubMed ID: 8393820
    [Abstract] [Full Text] [Related]

  • 16. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.
    Dey BR, Sukhatme VP, Roberts AB, Sporn MB, Rauscher FJ, Kim SJ.
    Mol Endocrinol; 1994 May 23; 8(5):595-602. PubMed ID: 8058069
    [Abstract] [Full Text] [Related]

  • 17. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product.
    Nakagama H, Heinrich G, Pelletier J, Housman DE.
    Mol Cell Biol; 1995 Mar 23; 15(3):1489-98. PubMed ID: 7862142
    [Abstract] [Full Text] [Related]

  • 18. Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product.
    Bardeesy N, Pelletier J.
    Nucleic Acids Res; 1998 Apr 01; 26(7):1784-92. PubMed ID: 9512553
    [Abstract] [Full Text] [Related]

  • 19. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.
    Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ.
    Science; 1992 Jul 31; 257(5070):674-8. PubMed ID: 1323141
    [Abstract] [Full Text] [Related]

  • 20. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
    Brown KW, Watson JE, Poirier V, Mott MG, Berry PJ, Maitland NJ.
    Oncogene; 1992 Apr 31; 7(4):763-8. PubMed ID: 1314370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.